KM Financial Solutions | FOCUS- Abbott to hike production of lower-cost glucose monitors as diabetes soars
47136
post-template-default,single,single-post,postid-47136,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

FOCUS- Abbott to hike production of lower-cost glucose monitors as diabetes soars

FOCUS- Abbott to hike production of lower-cost glucose monitors as diabetes soars

Abbott Laboratories
plans to ramp up manufacturing capacity for its lower-cost
continuous glucose monitor, the FreeStyle Libre, by three to
five times in the next few years, aiming to reach millions more
patients worldwide, the company told Reuters.

No Comments

Sorry, the comment form is closed at this time.